Stress-B-Plus Tablet: Contains Niacin instead of Niacinamide
Brand(s)
Last updated
Summary
Product
Stress-B-Plus Tablet
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| Douglas Laboratories | Stress-B-Plus Tablet | NPN 80064323 | Tablet | Biotin 200.0 micrograms Choline 26.0 milligrams Folate 400.0 micrograms Inositol 55.0 milligrams Niacinamide 200.0 milligrams Riboflavin 55.0 milligrams Thiamine 50.5 milligrams Vitamin B12 100.0 micrograms Vitamin B6 53.5 milligrams para-Aminobenzoic acid 55.0 milligrams Pantothenic acid 55.0 milligrams | 621338-1 |
Issue
Affected lot contains Niacin. Product should contain Niacinamide as per the label.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Nestle Canada Inc.
dba (Atrium Innovations/Douglas Laboratories Canada)
150 Via Renzo Drive,
Richmond Hill, ON L4S 0J7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-76328
Get notified
Receive emails about new and updated recall and safety alerts.